Dana-Farber/Brigham and Women's Cancer Center — Boston, Massachusetts

Dana-Farber/Brigham and Women's Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02115.

Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Dana-Farber/Brigham and Women's Cancer Center has participated in 34 clinical trials with 4 currently active.

Therapeutic areas: Lymphoma, Breast Carcinoma, Adult Acute Myeloid Leukemia in Remission.

Sponsors: Alliance for Clinical Trials in Oncology, Radiation Therapy Oncology Group, Harvard Medical School (HMS and HSDM).

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber/Brigham and Women's Cancer Center?

Dana-Farber/Brigham and Women's Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber/Brigham and Women's Cancer Center conducted?

Dana-Farber/Brigham and Women's Cancer Center has 34 clinical trials on record, with 4 currently active. Their work covers Lymphoma, Breast Carcinoma, Adult Acute Myeloid Leukemia in Remission.

Is Dana-Farber/Brigham and Women's Cancer Center accredited by Crixeo Clinical Trials?

Dana-Farber/Brigham and Women's Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber/Brigham and Women's Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.